Craft

Xtant Medical

Stock Price

$0.6

2024-10-29

Market Capitalization

$77.1 M

2024-10-29

Revenue

$133.9 M

FY, 2025

Xtant Medical Summary

Company Summary

Overview
Xtant Medical develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets. The Company's products serve the specialized needs of orthopedic and neurological surgeons, including ortho biologics for the promotion of bone healing, implants and instrumentation for the treatment of spinal disease, tissue grafts for the treatment of orthopedic disorders, and biologics to promote healing following cranial, and foot and ankle surgeries.
Type
Public
Status
Active
Founded
2006
HQ
Belgrade, MT, US | view all locations
Website
https://xtantmedical.com/
Cybersecurity rating
Sectors

Key People

  • Sean Browne, Chief Executive Officer

    • John Bakewell, Director, Chair of the Audit Committee

      • Michael Eggenberg, Director

        • Robert McNamara, Director

          LocationsView all

          2 locations detected

          • Belgrade, MT HQ

            United States

            664 Cruiser Ln

          • Miamisburg, OH

            United States

            452 Alexandersville Rd

          Xtant Medical Financials

          Summary Financials

          Revenue (FY, 2025)
          $133.9M
          Gross profit (FY, 2025)
          $84.3M
          Net income (FY, 2025)
          $5.0M
          Cash (FY, 2025)
          $17.1M
          EBIT (FY, 2025)
          $7.3M
          Enterprise value
          $80.4M

          Footer menu